Are the self-stigma and perceived stigma of patients treated with methadone or buprenorphine still a problem fifty years after the marketing authorization for opioid agonist treatment? The observational STIGMA study

Original research
by
Pinhal, Mélanie et al

Release Date

2024

Geography

France

Language of Resource

English

Full Text Available

Yes

Open Access / OK to Reproduce

Yes

Peer Reviewed

Yes

Objective

This study aimed to quantify self-stigma, explore some aspects of perceived stigma, determine the factors associated with greater self-stigma and examine whether the level of self-stigma was related to a delay in seeking care.

Findings/Key points

73 questionnaires were included in the analysis. Nearly two-thirds of the patients had a “moderate to high” level of self-stigma. These patients were significantly younger at OUD onset and were significantly more likely to have at least one dependent child than patients reporting a “very low to low” level of self-stigma. Nearly half of the participants experienced perceived stigma from a healthcare professional regarding their OUD or OAT, and nearly one-third of the participants were refused care from a healthcare professional because of their OUD or OAT. Moreover, a quarter of the sample reported delaying care due to fear of being stigmatized. 

Design/methods

This is a monocentric, cross-sectional study. Questionnaires were completed by participants who were outpatients of a hospital addiction medicine department with current or past opioid use disorder (OUD) who were still receiving or had received opioid agonist treatment (OAT). 

Keywords

About PWUD
Barriers and enablers
Hesitancy of prescribers
Hospitals
Opioids
Stigma
Substitution/OAT
Treatment/recovery